Gene therapy and solid-organ transplantation.


Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.

Cite this paper

@article{Akalin2002GeneTA, title={Gene therapy and solid-organ transplantation.}, author={Enver Akalin and Jonathan S. Bromberg}, journal={Kidney international}, year={2002}, volume={61 1 Suppl}, pages={S56-60} }